44 related articles for article (PubMed ID: 32552931)
1. [Expression and Significance of PD-1, TIM-3 and VISTA on T Cell of Acute Myeloid Leukemia Patients].
Ge MJ; Xu KL; Xu T; Tang YN; Li ZY; Yan ZL; Sun HY; Cheng H; Zhu F; Sang W; Huang YH; Qiu TT; Li DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):748-752. PubMed ID: 32552931
[TBL] [Abstract][Full Text] [Related]
2. Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia.
Huang S; Zhao Y; Lai W; Tan J; Zheng X; Zha X; Li Y; Chen S
Cancer Biol Ther; 2023 Dec; 24(1):2278229. PubMed ID: 37962843
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of aberrant PD-1 expression for acute leukemia prognosis.
Ruan Y; Wang J; Zhang Q; Wang H; Li C; Xu X; Zhai Z
Eur J Med Res; 2023 Sep; 28(1):383. PubMed ID: 37759316
[TBL] [Abstract][Full Text] [Related]
4. TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients.
Rakova J; Truxova I; Holicek P; Salek C; Hensler M; Kasikova L; Pasulka J; Holubova M; Kovar M; Lysak D; Kline JP; Racil Z; Galluzzi L; Spisek R; Fucikova J
Oncoimmunology; 2021 Mar; 10(1):1889822. PubMed ID: 33758676
[TBL] [Abstract][Full Text] [Related]
5. Increased PD-1 expression of bone marrow T-cells in acute myeloid leukaemia patients after stem cell transplantation, and its association with overall survival.
You E; Park CJ; Cho YU; Jang S; Lee MY; Kim H; Koh KN; Im HJ; Choi EJ; Lee JH; Lee KH
Ann Clin Biochem; 2024 Mar; 61(2):79-89. PubMed ID: 37314798
[TBL] [Abstract][Full Text] [Related]
6. Lactate acid promotes PD-1
Zhang Y; Huang Y; Hong Y; Lin Z; Zha J; Zhu Y; Li Z; Wang C; Fang Z; Zhou Z; Peng Y; Yu X; Liu L; Xu B
Int Immunopharmacol; 2024 Mar; 130():111765. PubMed ID: 38447414
[TBL] [Abstract][Full Text] [Related]
7. Expression of immune check point gene TIM-3 in patients newly diagnosed with acute myeloid leukemia: Significance and impact on outcome.
Kamal AM; Nabih NA; Elleboudy NS; Radwan SM
Oncol Lett; 2021 Apr; 21(4):325. PubMed ID: 33692857
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a prognostic risk-scoring model based on the level of TIM-3 expression in acute myeloid leukemia.
Huang W; Zheng S; Wang Q; Zhao N; Long Z
Sci Rep; 2023 Sep; 13(1):15658. PubMed ID: 37730831
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the frequencies of bone marrow lymphocyte subsets in adult acute myeloid leukemia at diagnosis.
Sun K; Wang J; Wang YZ; Shi ZY; Chang Y; Yuan XY; Liu YR; Jiang H; Jiang Q; Huang XJ; Qin YZ
Int J Lab Hematol; 2024 Apr; 46(2):294-302. PubMed ID: 38069563
[TBL] [Abstract][Full Text] [Related]
10. Tim-3 facilitates immune escape in benzene-induced acute myeloid leukemia mouse model by promoting macrophage M2 polarization.
Ning Q; Jian T; Cui S; Shi L; Jian X; He X; Zhang X; Li X
Ecotoxicol Environ Saf; 2023 Nov; 266():115532. PubMed ID: 37806131
[TBL] [Abstract][Full Text] [Related]
11. Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy.
Root JL; Desai PN; Ly C; Wang B; Jelloul FZ; Zhou J; Mackay S; Alfayez M; Matthews J; Pierce S; Reville PK; Daver N; Abbas HA
Cancer Res Commun; 2024 Mar; 4(3):671-681. PubMed ID: 38391202
[TBL] [Abstract][Full Text] [Related]
12. Expression of Galectin-9-related immune checkpoint receptors in B-cell acute lymphoblastic leukemia.
Akbar A; Asgarian-Omran H; Valadan R; Dindarloo MM; Najafi A; Kahrizi A; Poursheikhani A; Karami H; Naderi M; Sabeti S; Tehrani M
Iran J Basic Med Sci; 2023; 26(12):1468-1474. PubMed ID: 37970435
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint expression patterns on T cell subsets in light-chain amyloidosis: VISTA, PD-1, and TIGIT as potential therapeutic targets.
Wang J; Zhao Y; Liao P; Huang S; Huang Y; Chen S; Li Y; Zhong L
Blood Sci; 2024 Jan; 6(1):e00181. PubMed ID: 38226018
[TBL] [Abstract][Full Text] [Related]
14. PD-1 and TIGIT Are Highly Co-Expressed on CD8
Xu L; Liu L; Yao D; Zeng X; Zhang Y; Lai J; Zhong J; Zha X; Zheng R; Lu Y; Li M; Jin Z; Hebbar Subramanyam S; Chen S; Huang X; Li Y
Front Oncol; 2021; 11():686156. PubMed ID: 34490086
[TBL] [Abstract][Full Text] [Related]
15. C-5401331 identified as a novel T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) inhibitor to control acute myeloid leukemia (AML) cell proliferation.
Al Shahrani M; Gahtani RM; Makkawi M
Med Oncol; 2024 Jan; 41(3):63. PubMed ID: 38265498
[TBL] [Abstract][Full Text] [Related]
16. TIM3 and CTLA4 immune checkpoint polymorphisms are associated with acute myeloid leukemia in Saudi Arabia.
Alqahtani M; Aljuaimlani A; Al-Tamimi J; Alomar S; Mansour L
Hematology; 2024 Dec; 29(1):2329024. PubMed ID: 38536023
[TBL] [Abstract][Full Text] [Related]
17. PD-1H/VISTA mediates immune evasion in acute myeloid leukemia.
Kim TK; Han X; Hu Q; Vandsemb EN; Fielder CM; Hong J; Kim KW; Mason EF; Plowman RS; Wang J; Wang Q; Zhang JP; Badri T; Sanmamed MF; Zheng L; Zhang T; Alawa J; Lee SW; Zeidan AM; Halene S; Pillai MM; Chandhok NS; Lu J; Xu ML; Gore SD; Chen L
J Clin Invest; 2024 Feb; 134(3):. PubMed ID: 38060328
[TBL] [Abstract][Full Text] [Related]
18. Immune characteristics and prognostic implications of mucosal-associated invariant T cells in acute myeloid leukemia.
Peng Q; Huang R; Wang H; Xiao H; Wang Y; Zhai Z; Wang Z
Cancer Immunol Immunother; 2023 Dec; 72(12):4399-4414. PubMed ID: 37932426
[TBL] [Abstract][Full Text] [Related]
19. The Association between Immune Checkpoint Proteins and Therapy Outcomes in Acute Myeloid Leukaemia Patients.
Bolkun L; Tynecka M; Walewska A; Bernatowicz M; Piszcz J; Cichocka E; Wandtke T; Czemerska M; Wierzbowska A; Moniuszko M; Grubczak K; Eljaszewicz A
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760457
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of mRNA Expressions of TOX and NR4As in CD8+ T cells in Acute Leukemia.
Mohammadi M; Asgarian-Omran H; Najafi B; Najafi A; Valadan R; Karami H; Naderisoraki M; Alizadeforoutan M; Shekarriz R; Tehrani M
Iran J Immunol; 2023 Dec; 20(4):438-445. PubMed ID: 37961948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
